Higher-dose glutathione therapy for Parkinson's disease in Japan: is it really safe?
Yutaka
Y
Naito
Ko
K
Matsuo
Yasumasa
Y
Kokubo
Yugo
Y
Narita
Hidekazu
H
Tomimoto
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005978:Glutathione / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007564:Japan; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D005978:Glutathione